InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
| Product | Citation | Year | Journal | Authors | Page |
|---|---|---|---|---|---|
| RAW-Blue™ Cells | The Potency of Cowpea Mosaic Virus Particles for Cancer In Situ Vaccination I... | 2023 | Mol Pharm. | Jung E. et al. | DOI: 10.1021/acs.molpharmaceut.3c00214 |
| HEK-Blue™ LPS Detection Kit 2 | Heterogeneity of Lipopolysaccharide as Source of Variability in Bioassays and... | 2023 | Int J Mol Sci. | Fux A.C. et al. | DOI: 10.3390/ijms24098395 |
| 3'3'-cGAMP | Stimulator of interferon genes (STING) expression in the enteric nervous syst... | 2023 | Neurogastroenterol Motil. | Dharshika C. et al. | DOI: 10.1111/nmo.14553 |
| 2'3'-cGAMP | Stimulator of interferon genes (STING) expression in the enteric nervous syst... | 2023 | Neurogastroenterol Motil. | Dharshika C. et al. | DOI: 10.1111/nmo.14553 |
| DMXAA | Stimulator of interferon genes (STING) expression in the enteric nervous syst... | 2023 | Neurogastroenterol Motil. | Dharshika C. et al. | DOI: 10.1111/nmo.14553 |
| QUANTI-Blue™ | Human IL-35 Inhibits the Bioactivity of IL-12 and Its Interaction with IL-12Rβ2. | 2023 | Immunohorizons | Mahfooz N.S. et al. | DOI: 10.4049/immunohorizons.2300039 |
| IL-12 Reporter HEK 293 Cells | Human IL-35 Inhibits the Bioactivity of IL-12 and Its Interaction with IL-12Rβ2. | 2023 | Immunohorizons | Mahfooz N.S. et al. | DOI: 10.4049/immunohorizons.2300039 |
| THP1-Dual™ Cells | Mesenchymal stromal cells and alpha-1 antitrypsin have a strong synergy in mo... | 2023 | Theranostics | Han L. et al. | DOI: 10.7150/thno.83942 |
| RAW-Dual™ Cells | Mesenchymal stromal cells and alpha-1 antitrypsin have a strong synergy in mo... | 2023 | Theranostics | Han L. et al. | DOI: 10.7150/thno.83942 |
| TLR4 agonist preparation - MPLA-SM | TLR4 Agonist MPLA Ameliorates Heavy-Ion Radiation Damage via Regulating DNA D... | 2023 | Radiat Res. | Liu T. et al. | DOI: 10.1667/RADE-22-00200.1 |
| Puromycin | DYNLT1 promotes mitochondrial metabolism to fuel breast cancer development by... | 2023 | Mol Med. | Huang L. et al. | DOI: 10.1186/s10020-023-00663-0 |
| Poly(dA:dT) | 1-Methylnicotinamide (1-MNA) inhibits the activation of the NLRP3 inflammasom... | 2023 | Int Immunopharmacol. | Sidor K. et al. | DOI: 10.1016/j.intimp.2023.110445 |
| ASC-GFP Reporter Monocytes | 1-Methylnicotinamide (1-MNA) inhibits the activation of the NLRP3 inflammasom... | 2023 | Int Immunopharmacol. | Sidor K. et al. | DOI: 10.1016/j.intimp.2023.110445 |
| Normocin™ - Antimicrobial Reagent | 1-Methylnicotinamide (1-MNA) inhibits the activation of the NLRP3 inflammasom... | 2023 | Int Immunopharmacol. | Sidor K. et al. | DOI: 10.1016/j.intimp.2023.110445 |
| LPS-PG (Lipopolysaccharide from P. gingivalis) | Glipizide Alleviates Periodontitis Pathogenicity via Inhibition of Angiogenes... | 2023 | Inflammation | Guo X. et al. | DOI: 10.1007/s10753-023-01850-1 |
| LPS-EB (LPS from E. coli O111:B4) | Reduced mitochondrial calcium uptake in macrophages is a major driver of infl... | 2023 | Nat Aging | Seegren P.V. et al. | DOI: 10.1038/s43587-023-00436-8 |
| Nigericin | Reduced mitochondrial calcium uptake in macrophages is a major driver of infl... | 2023 | Nat Aging | Seegren P.V. et al. | DOI: 10.1038/s43587-023-00436-8 |
| R848 (Resiquimod) | Human RELA dominant-negative mutations underlie type I interferonopathy with ... | 2023 | J Exp Med. | Moriya K. et al. | DOI: 10.1084/jem.20212276 |
| TL8-506 | Human RELA dominant-negative mutations underlie type I interferonopathy with ... | 2023 | J Exp Med. | Moriya K. et al. | DOI: 10.1084/jem.20212276 |
| LPS-EB (LPS from E. coli O111:B4) | In vitro immune and redox response induced by cationic cellulose-based nanoma... | 2023 | Toxicol In Vitro | Tobias T. et al. | DOI: 10.1016/j.tiv.2023.105616 |